Kathryn J. Collier - Jun 16, 2025 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Director
Signature
Christopher Aker, Attorney in Fact
Stock symbol
RGLS
Transactions as of
Jun 16, 2025
Transactions value $
$60,060
Form type
4
Date filed
6/18/2025, 05:00 PM
Previous filing
Apr 30, 2025
Next filing
Jun 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Collier Kathryn J Director C/O REGULUS THERAPEUTICS, 4224 CAMPUS POINT COURT #210, SAN DIEGO Christopher Aker, Attorney in Fact 2025-06-18 0001737436

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Options Exercise $13.8K +1.4K +2.1% $9.90 67.8K Jun 16, 2025 Direct
transaction RGLS Common Stock Options Exercise $25.8K +2.6K +4.16% $9.90 65.2K Jun 17, 2025 Direct
transaction RGLS Common Stock Options Exercise $20.5K +2.33K +3.84% $8.80 62.9K Jun 17, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGLS Stock Option (Right to Buy) Options Exercise $0 -1.4K -34.9% $0.00 2.6K Jun 16, 2025 Common Stock 1.4K $9.90 Direct
transaction RGLS Stock Option (Right to Buy) Options Exercise $0 -2.6K -100% $0.00 0 Jun 17, 2025 Common Stock 2.6K $9.90 Direct
transaction RGLS Stock Option (Right to Buy) Options Exercise $0 -2.33K -100% $0.00 0 Jun 17, 2025 Common Stock 2.33K $8.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.